Literature DB >> 12451038

Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma.

Takashi Okuyama1, Masatoshi Oya, Masahiko Yamaguchi.   

Abstract

PURPOSE: Budding (sprouting) along the invasive margin is reported to be associated with high malignant potential of colorectal carcinoma. We examined the prognostic significance of budding in colorectal mucinous carcinoma. PATIENTS AND METHODS: Surgically resected specimens from 31 patients with colorectal mucinous carcinoma were studied. The median postoperative follow-up was 27 months. The presence of budding was examined according to Morodomi's criteria using hematoxylin-eosin-stained sections.
RESULTS: Budding was found in 18 lesions (58%). Budding was more frequently observed in lesions with venous invasion and lymph node metastasis than in those without (P = 0.04, P = 0.03, respectively). The incidence of budding was higher in lesions with distant metastasis than in those without (P < 0.03). Overall recurrence and peritoneal disseminated recurrence were significantly more frequent in patients with budding-positive lesions than in those with budding-negative lesions (P = 0.05, P = 0.04, respectively). The cumulative 5-year survival rate of curative resected cases was lower in patients with budding-positive lesions than in those with budding-negative lesions (25.0% versus 90.9%, P = 0.01, log-rank test). Moreover, both the univariate and multivariate proportional hazard models revealed that the presence of budding was the only significant co-factor of postoperative survival.
CONCLUSION: Budding is a pathological marker suggesting high malignant potential and decreased postoperative survival in patients with colorectal mucinous carcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 12451038     DOI: 10.1093/jjco/hyf089

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  9 in total

1.  Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type.

Authors:  Dae Kyung Sohn; Hee Jin Chang; Ji Won Park; Dong Hyun Choi; Kyung Su Han; Chang Won Hong; Kyung Hae Jung; Dae Yong Kim; Seok-Byung Lim; Hyo Seong Choi; Seung-Yong Jeong
Journal:  J Clin Pathol       Date:  2006-09-22       Impact factor: 3.411

2.  Assessment of qualitative changes of Acid mucins among sudanese colorectal carcinoma patients.

Authors:  Yosef Mohamed-Azzam Zakout; Yousra Altegani Ezeldeen
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 3.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

Review 4.  Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases.

Authors:  Sean C Glasgow; Joshua I S Bleier; Lawrence J Burgart; Charles O Finne; Ann C Lowry
Journal:  J Gastrointest Surg       Date:  2012-01-19       Impact factor: 3.452

5.  Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.

Authors:  Kazuyuki Saito; Takashi Okuyama; Shunya Miyazaki; Haruka Oi; Takashi Mitsui; Takuji Noro; Emiko Takeshita; Yuko Ono; Taizen Urahashi; Hidehiro Tajima; Hideyuki Yoshitomi
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

6.  Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer.

Authors:  Katarzyna Guzinska-Ustymowicz; Andrzej Kemona
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

7.  Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.

Authors:  Sang-Sik Ha; Hong-Jo Choi; Ki-Jae Park; Jung-Min Kim; Sung-Heun Kim; Young-Hoon Roh; Hyuk-Chan Kwon; Mee-Sook Roh
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

Review 8.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Oncotarget       Date:  2010-11

Review 9.  Tumor Budding: The Name is EMT. Partial EMT.

Authors:  Alexandru Dan Grigore; Mohit Kumar Jolly; Dongya Jia; Mary C Farach-Carson; Herbert Levine
Journal:  J Clin Med       Date:  2016-04-29       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.